Invest in API Medicines | FDI Opportunities

INVEST IN AFRICA NOW

Set-up your Business in Africa's Key Industrial Zones

Name *

Email *

Phone No. *

Tick if your WhatsApp number is same as the phone number

Investment Sector

Business Opportunity

How may we assist you?

*Note: Name, Email and Phone Number are mandatory.

I agree to the AFI privacy policy.*

I agree to receive e-communications from AFI.

THANK YOU

Our team will get back to you shortly.

Invest in local API and medicine production to unlock a high-growth market in Africa's booming pharmaceutical sector! Improve healthcare access, reduce import reliance, and create a socially impactful investment.

$1,500 Bn

Market Size

3-5%

CAGR

$1,900 Bn

Forecast

API & Medicines by-product markets

Veterinary Medicines

Generic Medicines

Nutraceuticals

Personalized Medicine

Bulk Active Pharmaceutical Ingredients

Pharmaceutical Intermediates

API & MEDICINE BUSINESS ADVANTAGES IN AFRICA

With a rapidly growing population of over 1.3 billion, the demand for affordable and accessible medicines is immense. This creates a multi-billion dollar market waiting to be tapped.
Currently, Africa relies heavily on imported medicines, often at high costs and with supply chain vulnerabilities. Investing in local API and medicine production fosters import substitution and ensures greater access to essential drugs for African populations.
African governments are increasingly prioritizing pharmaceutical manufacturing as a key driver of healthcare security. This translates to potential tax breaks, streamlined regulations, and many other incentives.
Africa boasts a young and growing talent pool in science and technology. This, coupled with potentially lower operating costs compared to developed markets, presents a competitive advantage for investors.
Partner with established pharmaceutical companies for local production.
The strategic location also offers the potential to serve not only the continent but also neighboring regions, creating a vast market for locally produced APIs and medicines.